Treatment of Recently Acquired Hepatitis C Virus Infection

NCT01336010 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Kirby Institute